BMJ  2006;332:1039 (29 April), doi:10.1136/bmj.332.7548.1039

reviews

TV

Drug Trials—the Dark Side: This World

The first 150 words of the full text of this article appear below.

An advert posted inside some London buses shrieks, "Drop by today—it could be a beneficial visit!" Placed by the pharmaceutical services company PAREXEL, it seeks volunteers for research—at Northwick Park Hospital. The recent disastrous trial of the monoclonal antibody TGN 1412 at that venue has heightened the public's interest in clinical drug studies. And the long term result may be increased scepticism, such that fewer people in the United Kingdom will be willing to participate in clinical research, no matter how upbeat the recruitment messages.

In addressing this problem, the pharmaceutical industry is, predictably, well ahead of the game. For instance, clinical trials are increasingly being conducted in developing countries that offer a rich source of suitable and apparently willing patients. Drug Trials—the Dark Side was a compelling documentary on how drug companies are targeting India for this purpose.

The scene was set by the comments of a patient-recruitment agent, . . . [Full text of this article]

Ike.Iheanacho@which.co.uk

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

Research for profit

Des Spence
BMJ 2006 332: 1155-1156. [Extract] [Full Text]

This article has been cited by other articles:

• Spence, D. (2006). Research for profit.. BMJ 332: 1155-1156 [Full text]  

Rapid Responses:

Read all Rapid Responses

Research for Profit

Des Spence
bmj.com, 28 Apr 2006 [Full text]

Need for clinical and research ethics simultaneously

Jagdishwar Srivastava
bmj.com, 5 May 2006 [Full text]

Online poll

Find out more >>